Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors

Urticarial eruptions and angioedema are the most common cutaneous reactions in patients undergoing mRNA COVID-19 vaccinations. The vasoactive peptide bradykinin has long been known to be involved in angioedema and recently also in urticaria. Bradykinin is mainly catabolized by angiotensin-converting...

Descripción completa

Detalles Bibliográficos
Autores principales: Cugno, Massimo, Consonni, Dario, Lombardi, Andrea, Bono, Patrizia, Oggioni, Massimo, Uceda Renteria, Sara, Pesatori, Angela Cecilia, Castaldi, Silvana, Riboldi, Luciano, Bordini, Lorenzo, Nava, Carlo Domenico, Ceriotti, Ferruccio, Torri, Adriana, Tafuri, Francesco, Ghigliazza, Gabriele, Peyvandi, Flora, Bandera, Alessandra, Gori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473401/
https://www.ncbi.nlm.nih.gov/pubmed/34579248
http://dx.doi.org/10.3390/vaccines9091011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473401/
https://www.ncbi.nlm.nih.gov/pubmed/34579248
http://dx.doi.org/10.3390/vaccines9091011

Ejemplares similares